These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16167024)

  • 1. A dramatic response to long-acting octreotide in metastatic hepatocellular carcinoma.
    Deming DA; Stella AL; Holen KD; Ku G; O'Reilly EM
    Clin Adv Hematol Oncol; 2005 Jun; 3(6):468-72; discussion 472-4. PubMed ID: 16167024
    [No Abstract]   [Full Text] [Related]  

  • 2. Regression of a hepatocellular carcinoma following treatment with octreotide and tamoxifen in a patient with advanced alcoholic cirrhosis.
    Senturk H; Canbakan B; Cumali R
    J Gastroenterol Hepatol; 2004 Jun; 19(6):719-20. PubMed ID: 15151636
    [No Abstract]   [Full Text] [Related]  

  • 3. The results of a randomized study on the use of long-acting octreotide in hepatocellular carcinoma.
    Borbath I; Horsmans Y
    Hepatology; 2003 Feb; 37(2):477-8; author reply 478. PubMed ID: 12575712
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of sandostatin LAR in treating patients with advanced hepatocellular cancer.
    Dimitroulopoulos D; Xinopoulos D; Tsamakidis K; Zisimopoulos A; Andriotis E; Markidou S; Panagiotakos D; Chrysohoou C; Bazinis A; Paraskevas E
    Hepatogastroenterology; 2002; 49(47):1245-50. PubMed ID: 12239914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete, long-standing regression of hepatocellular carcinoma after somatostatin analogue treatment.
    Rahmi G; Malka D; Tomasic G; Dromain C; Ducreux M; Boige V
    J Clin Oncol; 2007 Jun; 25(16):e15-6. PubMed ID: 17538153
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.
    Yuen MF; Poon RT; Lai CL; Fan ST; Lo CM; Wong KW; Wong WM; Wong BC
    Hepatology; 2002 Sep; 36(3):687-91. PubMed ID: 12198662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tamoxifen and hepatocarcinoma].
    Mondragón Sánchez R
    Rev Gastroenterol Mex; 1998; 63(3):169. PubMed ID: 10068765
    [No Abstract]   [Full Text] [Related]  

  • 8. [Somatostatin analogue (octreotide)].
    Sano K; Makuuchi M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():674-7. PubMed ID: 11762035
    [No Abstract]   [Full Text] [Related]  

  • 9. [A therapeutic study of hepatocellular carcinoma using octreotide (HECTOR). Hepatocellular Carcinoma: Treatment with Octreotide].
    Allgaier HP; Becker G; Blum HE
    Dtsch Med Wochenschr; 2000 Mar; 125(11):320. PubMed ID: 10761474
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical outcome of a cohort of 63 patients with hepatocellular carcinoma treated with octreotide.
    Rabe C; Pilz T; Allgaier HP; Halm U; Strasser C; Wettstein M; Sauerbruch T; Caselmann WH
    Z Gastroenterol; 2002 Jun; 40(6):395-400. PubMed ID: 12055662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study.
    Kouroumalis E; Skordilis P; Thermos K; Vasilaki A; Moschandrea J; Manousos ON
    Gut; 1998 Mar; 42(3):442-7. PubMed ID: 9577356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chest radiography in hepatocellular carcinoma (author's transl)].
    Torres-Salinas M; Rigau J; Bruguera M; Rodés J
    Med Clin (Barc); 1981 Dec; 77(10):415-9. PubMed ID: 6276628
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatocellular carcinoma with hepatic and pulmonary metastasis, inferior vena cava and left pulmonary artery thrombosis in a patient with asymptomatic hepatitis C. Case report.
    Bălăceanu A; Diaconu C; Mateescu D; Stănică A
    Med Ultrason; 2010 Dec; 12(4):345-8. PubMed ID: 21210022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of radiological investigations in diagnosing hepatocellular carcinoma in cirrhotic livers.
    Rao AR; Chui AK; Shi LW; Waugh R; Pillay P; Sheil AG
    Transplant Proc; 2003 Feb; 35(1):348-9. PubMed ID: 12591434
    [No Abstract]   [Full Text] [Related]  

  • 15. Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide.
    Cebon J; Findlay M; Hargreaves C; Stockler M; Thompson P; Boyer M; Roberts S; Poon A; Scott AM; Kalff V; Garas G; Dowling A; Crawford D; Ring J; Basser R; Strickland A; Macdonald G; Green M; Nowak A; Dickman B; Dhillon H; Gebski V;
    Br J Cancer; 2006 Oct; 95(7):853-61. PubMed ID: 16953241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin analogs and hepatocellular carcinoma: Not dead yet?
    Raftery L; O'Neil BH
    Cancer Biol Ther; 2009 Nov; 8(21):2040-1. PubMed ID: 19823044
    [No Abstract]   [Full Text] [Related]  

  • 17. Octreotide treatment of hepatocellular carcinoma.
    Kouroumalis E; Samonakis D; Skordilis P
    Hepatology; 2003 Feb; 37(2):477. PubMed ID: 12540801
    [No Abstract]   [Full Text] [Related]  

  • 18. Metastatic hepatic carcinoid associated with ectopic ACTH syndrome, resistant to octreotide and ketoconazole therapy.
    Khan MQ; Al Kahtani KM; Al-Ashgar H
    Ann Saudi Med; 2004; 24(5):386-90. PubMed ID: 15573856
    [No Abstract]   [Full Text] [Related]  

  • 19. Tamoxifen combined with octreotide or regular chemotherapeutic agents in treatment of primary liver cancer: a randomized controlled trial.
    Pan DY; Qiao JG; Chen JW; Huo YC; Zhou YK; Shi HA
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):211-5. PubMed ID: 14599971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superselective transcatheter arterial chemoembolisation of an unresectable hepatocellular carcinoma using three-dimensional rotational angiography.
    Takao H; Doi I; Watanabe T
    Br J Radiol; 2007 May; 80(953):e85-7. PubMed ID: 17638836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.